JPH0419968B2 - - Google Patents

Info

Publication number
JPH0419968B2
JPH0419968B2 JP58135265A JP13526583A JPH0419968B2 JP H0419968 B2 JPH0419968 B2 JP H0419968B2 JP 58135265 A JP58135265 A JP 58135265A JP 13526583 A JP13526583 A JP 13526583A JP H0419968 B2 JPH0419968 B2 JP H0419968B2
Authority
JP
Japan
Prior art keywords
dds
leprosy
brodimoprim
culture
cultures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58135265A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5933218A (ja
Inventor
Karuru Zaideru Yoahimu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JPS5933218A publication Critical patent/JPS5933218A/ja
Publication of JPH0419968B2 publication Critical patent/JPH0419968B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP58135265A 1982-07-29 1983-07-26 抗マイコバクテリア組成物 Granted JPS5933218A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4600/82A CH651473A5 (de) 1982-07-29 1982-07-29 Pharmazeutisches praeparat.
CH4600/82-8 1982-07-29

Publications (2)

Publication Number Publication Date
JPS5933218A JPS5933218A (ja) 1984-02-23
JPH0419968B2 true JPH0419968B2 (de) 1992-03-31

Family

ID=4279115

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58135265A Granted JPS5933218A (ja) 1982-07-29 1983-07-26 抗マイコバクテリア組成物

Country Status (8)

Country Link
JP (1) JPS5933218A (de)
BE (1) BE897397A (de)
CH (1) CH651473A5 (de)
DE (1) DE3326165A1 (de)
FR (1) FR2531861B1 (de)
GB (1) GB2125293B (de)
IT (1) IT1171692B (de)
NL (1) NL194535C (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK387687A (da) * 1986-07-28 1988-01-29 Warner Lambert Co Fremstilling af farmaceutisk praeparat til behandling af infektioner med mycobacterium avium-intracellulare komplekset

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE419444B (sv) * 1973-11-08 1981-08-03 Hoffmann La Roche Forfarande for framstellning av nya 2,4-diamino-5-bensylpyrimidinderivat
ZW10681A1 (en) * 1980-06-26 1982-02-24 Hoffmann La Roche Antibacterial agents
GB2082063A (en) * 1980-08-15 1982-03-03 Haughey Edward Antibacterial drug

Also Published As

Publication number Publication date
DE3326165C2 (de) 1993-07-22
GB2125293A (en) 1984-03-07
DE3326165A1 (de) 1984-04-12
GB8320438D0 (en) 1983-09-01
IT1171692B (it) 1987-06-10
NL8302579A (nl) 1984-02-16
JPS5933218A (ja) 1984-02-23
BE897397A (fr) 1984-01-30
NL194535C (nl) 2002-07-02
FR2531861B1 (fr) 1987-08-28
NL194535B (nl) 2002-03-01
FR2531861A1 (fr) 1984-02-24
CH651473A5 (de) 1985-09-30
GB2125293B (en) 1985-11-13
IT8322089A0 (it) 1983-07-15
IT8322089A1 (it) 1985-01-15

Similar Documents

Publication Publication Date Title
Crowle et al. Chlorpromazine: a drug potentially useful for treating mycobacterial infections
Birkmayer et al. Implications of combined treatment with'Madopar'and L-deprenil in Parkinson's disease: a long-term study
Wayne et al. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis
TWI363625B (en) Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
TW457089B (en) Pharmaceutical composition for treating or inhibiting the growth of tumors or cancers susceptible to treatment
JPH0641412B2 (ja) プロリンヒドロキシラーゼおよびリジンヒドロキシラーゼ抑制のための薬剤
Petri Chemotherapy of tuberculosis, Mycobacterium avium complex disease, and leprosy
Hobby et al. In vitro and in vivo activity of streptomycin and isoniazid singly and in combination
Jenne et al. Correlation of in vitro and in vivo kinetics with clinical use of isoniazid, ethambutol, and rifampin
PT655249E (pt) Moenomicina como medicamento para o tratamento de ulceras gastricas
Gilbert et al. Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis
KR890003378A (ko) 혐기성균에 대해 항균작용을 갖는 나프티리딘 화합물
Lawrence Bacteriostatic Actions of Three Thiazol Derivatives of Sulfanila-mide upon Bacteria in Broth Cultures
Mauel et al. Intracellular parasite killing induced by electron carriers. II. Correlation between parasite killing and the induction of oxidative events in macrophages
JP2007537242A (ja) 抗マイコバクテリア医薬組成物
Tsui et al. Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum
NL194535C (nl) Farmaceutisch preparaat voor de behandeling van lepra dat diaminodifenylsulfon bevat.
US3192113A (en) N, n'-dialkylenediamines as antitubercular agents
Evans et al. Hydrazide antidepressants possess novel antileishmanial activity in vitro and in vivo
Wright et al. Candidacidal activity of myeloperoxidase: therapeutic influence of the enzyme in vivo
Nakamura et al. Effect of purine derivatives on Trypanosoma cruzi in vitro
Vlasveld et al. Treatment with deferoxamine: a real risk factor for mucormycosis
TRNKA VI. Tetracyclines
WO1994027606A1 (en) Method of treating helicobacter pylori infection
BANERJEE Ciproftoxacin (4-q uinolone)